Low Brachial Artery Flow-Mediated Dilation Predicts Worse Prognosis in Hospitalized Patients with COVID-19.
COVID-19
SARS-CoV-2
bFMD
endothelial dysfunction
pneumonia
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
22 Nov 2021
22 Nov 2021
Historique:
received:
03
10
2021
revised:
15
11
2021
accepted:
18
11
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
28
11
2021
Statut:
epublish
Résumé
Endothelial injury can be induced by coronavirus disease 2019 (COVID-19) and seems to exert a crucial pathogenic role in its most severe clinical manifestations. We aimed to investigate the association between brachial artery flow-mediated dilation (bFMD), a potential clinical and non-invasive measure of endothelial function, and in-hospital prognosis of COVID-19 patients. Brachial artery flow-mediated dilation was assessed in hospitalized COVID-19 patients within 48 h of hospital admission. The association between bFMD and either intensive care unit (ICU) admission or in-hospital death was explored using univariable and multivariable analyses. Four hundred and eight patients were enrolled. Significantly lower bFMD values emerged in COVID-19 patients with either radiographic signs of pneumonia, respiratory distress, or the need for non-invasive ventilation compared with patients without these signs ( Low bFMD predicts an unfavorable in-hospital prognosis in COVID-19 patients. The measurement of bFMD may be clinically useful in the prognostic stratification of COVID-19 patients upon hospital admission.
Sections du résumé
BACKGROUND
BACKGROUND
Endothelial injury can be induced by coronavirus disease 2019 (COVID-19) and seems to exert a crucial pathogenic role in its most severe clinical manifestations. We aimed to investigate the association between brachial artery flow-mediated dilation (bFMD), a potential clinical and non-invasive measure of endothelial function, and in-hospital prognosis of COVID-19 patients.
METHODS
METHODS
Brachial artery flow-mediated dilation was assessed in hospitalized COVID-19 patients within 48 h of hospital admission. The association between bFMD and either intensive care unit (ICU) admission or in-hospital death was explored using univariable and multivariable analyses.
RESULTS
RESULTS
Four hundred and eight patients were enrolled. Significantly lower bFMD values emerged in COVID-19 patients with either radiographic signs of pneumonia, respiratory distress, or the need for non-invasive ventilation compared with patients without these signs (
CONCLUSIONS
CONCLUSIONS
Low bFMD predicts an unfavorable in-hospital prognosis in COVID-19 patients. The measurement of bFMD may be clinically useful in the prognostic stratification of COVID-19 patients upon hospital admission.
Identifiants
pubmed: 34830738
pii: jcm10225456
doi: 10.3390/jcm10225456
pmc: PMC8621380
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Angiogenesis. 2021 Aug;24(3):505-517
pubmed: 33449299
Clin Immunol. 2021 Jan;222:108615
pubmed: 33203513
Front Physiol. 2021 Jan 15;11:605908
pubmed: 33519510
Gut. 2021 Jan;70(1):76-84
pubmed: 32732368
J Vis Exp. 2014 Oct 22;(92):e52070
pubmed: 25406739
Nat Commun. 2020 Oct 30;11(1):5493
pubmed: 33127906
JAMA Intern Med. 2021 Apr 1;181(4):471-478
pubmed: 33351068
Nat Rev Immunol. 2020 Jul;20(7):389-391
pubmed: 32439870
Atherosclerosis. 2020 Dec;314:58-62
pubmed: 33161318
Med Hypotheses. 2020 Nov;144:110229
pubmed: 33254535
Respir Med. 2021 Aug-Sep;185:106469
pubmed: 34175806
Sci Rep. 2016 Jun 29;6:28741
pubmed: 27353425
Pathog Glob Health. 2020 Sep;114(6):281-282
pubmed: 32584660
J Infect. 2021 May;82(5):186-230
pubmed: 33275957
N Engl J Med. 2020 Nov 12;383(20):1993-1994
pubmed: 33108107
Lancet Haematol. 2020 Aug;7(8):e575-e582
pubmed: 32619411
Lancet Respir Med. 2021 Apr;9(4):320-321
pubmed: 33444541
Microvasc Res. 2021 Mar;134:104119
pubmed: 33278457
J Clin Med Res. 2020 Jun;12(6):329-343
pubmed: 32587649
Metabolism. 2020 Dec;113:154375
pubmed: 32976855
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
Cardiovasc Res. 2020 Aug 1;116(10):e132-e133
pubmed: 32420587
Cardiol Ther. 2019 Dec;8(2):179-191
pubmed: 31578675
Cardiovasc Res. 2020 Dec 1;116(14):2177-2184
pubmed: 32750108
Obesity (Silver Spring). 2021 Sep 23;:
pubmed: 34554646
Clin Infect Dis. 2006 May 1;42(9):1325-32
pubmed: 16586393
Eur Heart J. 2020 Sep 1;41(32):3038-3044
pubmed: 32882706
Front Microbiol. 2019 Dec 03;10:2752
pubmed: 31849894
Daru. 2020 Dec;28(2):789-793
pubmed: 32385829
Angiology. 2021 Feb;72(2):122-130
pubmed: 32864982
Acta Cardiol Sin. 2019 Mar;35(2):165-178
pubmed: 30930564
J Immunol. 2004 Jul 15;173(2):874-82
pubmed: 15240674
J Infect Dis. 2020 Nov 9;222(11):1789-1793
pubmed: 32812049
Drugs. 2020 Sep;80(14):1383-1396
pubmed: 32705604
Atherosclerosis. 2005 Feb;178(2):345-50
pubmed: 15694944
Int J Infect Dis. 2004 Jul;8(4):223-6
pubmed: 15234326
Expert Opin Ther Targets. 2020 Aug;24(8):723-730
pubmed: 32594778
Am J Physiol Heart Circ Physiol. 2021 Jan 1;320(1):H404-H410
pubmed: 33306450
Viruses. 2020 Dec 26;13(1):
pubmed: 33375371
Atherosclerosis. 2005 Dec;183(2):349-54
pubmed: 15899485
Hypertension. 2007 Feb;49(2):317-21
pubmed: 17200433
BMJ. 2020 Sep 9;370:m3339
pubmed: 32907855